Literature DB >> 15582224

Mesolimbic dopaminergic pathways in fear conditioning.

Marie A Pezze1, Joram Feldon.   

Abstract

One of the most common paradigms used to study the biological basis of emotion, as well as of learning and memory, is Pavlovian fear conditioning. In the acquisition phase of a fear conditioning experiment, an emotionally neutral conditioned stimulus (CS)--which can either be a discrete stimulus, such as a tone, or a contextual stimulus, such as a specific environment--is paired with an aversive unconditioned stimulus (US), for example a foot shock. As a result, the CS elicits conditioned fear responses when subsequently presented alone during the expression phase of the experiment. While considerable work has been done in relating specific circuits of the brain to fear conditioning, less is known about its regulation by neuromodulators; the understanding of which would be of therapeutic relevance for fear related diseases such as phobia, panic attacks, post traumatic stress disorder, obsessive compulsive disorder, or generalized anxiety disorder. Dopamine is one of the neuromodulators most potently acting on the mechanisms underlying states of fear and anxiety. Recently, a growing body of evidence has suggested that dopaminergic mechanisms are significant for different aspects of affective memory, namely its formation, expression, retrieval, and extinction. The aim of this review is to clarify the complex actions of dopamine in fear conditioning with respect to the wide-spread distribution of dopaminergic innervation over structures constituting the fear related circuitry. A particular effort is made to understand how dopamine in the amygdala, medial prefrontal cortex and nucleus accumbens--target structures of the mesolimbic dopamine system originating from the ventral tegmental area--could relate to different aspects of fear conditioning.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15582224     DOI: 10.1016/j.pneurobio.2004.09.004

Source DB:  PubMed          Journal:  Prog Neurobiol        ISSN: 0301-0082            Impact factor:   11.685


  176 in total

1.  Increased dopamine receptor activity in the nucleus accumbens shell ameliorates anxiety during drug withdrawal.

Authors:  Anna K Radke; Jonathan C Gewirtz
Journal:  Neuropsychopharmacology       Date:  2012-06-13       Impact factor: 7.853

Review 2.  Striatal mechanisms underlying movement, reinforcement, and punishment.

Authors:  Alexxai V Kravitz; Anatol C Kreitzer
Journal:  Physiology (Bethesda)       Date:  2012-06

3.  Coherent amygdalocortical theta promotes fear memory consolidation during paradoxical sleep.

Authors:  Daniela Popa; Sevil Duvarci; Andrei T Popescu; Clément Léna; Denis Paré
Journal:  Proc Natl Acad Sci U S A       Date:  2010-03-23       Impact factor: 11.205

4.  Limited convergence of rhinal cortical and dopaminergic inputs in the rat basolateral amygdala: an ultrastructural analysis.

Authors:  Courtney R Pinard; Franco Mascagni; Jay F Muller; Alexander J McDonald
Journal:  Brain Res       Date:  2010-03-24       Impact factor: 3.252

Review 5.  Dopamine in motivational control: rewarding, aversive, and alerting.

Authors:  Ethan S Bromberg-Martin; Masayuki Matsumoto; Okihide Hikosaka
Journal:  Neuron       Date:  2010-12-09       Impact factor: 17.173

Review 6.  Opponency revisited: competition and cooperation between dopamine and serotonin.

Authors:  Y-Lan Boureau; Peter Dayan
Journal:  Neuropsychopharmacology       Date:  2010-09-29       Impact factor: 7.853

Review 7.  Perinatal exposure to bisphenol A at the intersection of stress, anxiety, and depression.

Authors:  Kimberly R Wiersielis; Benjamin A Samuels; Troy A Roepke
Journal:  Neurotoxicol Teratol       Date:  2020-04-11       Impact factor: 3.763

Review 8.  Dopamine reward circuitry: two projection systems from the ventral midbrain to the nucleus accumbens-olfactory tubercle complex.

Authors:  Satoshi Ikemoto
Journal:  Brain Res Rev       Date:  2007-05-17

9.  Primary and Secondary Variants of Psychopathy in a Volunteer Sample Are Associated With Different Neurocognitive Mechanisms.

Authors:  Arjun Sethi; Eamon McCrory; Vanessa Puetz; Ferdinand Hoffmann; Annchen R Knodt; Spenser R Radtke; Bartholomew D Brigidi; Ahmad R Hariri; Essi Viding
Journal:  Biol Psychiatry Cogn Neurosci Neuroimaging       Date:  2018-04-12

Review 10.  A role for phasic dopamine release within the nucleus accumbens in encoding aversion: a review of the neurochemical literature.

Authors:  Jennifer M Wenzel; Noah A Rauscher; Joseph F Cheer; Erik B Oleson
Journal:  ACS Chem Neurosci       Date:  2014-12-24       Impact factor: 4.418

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.